Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “De Novo Renal Transplantation”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT00408681
What this trial is testing

Lithium Carbonate in Treating Patients With Acute Intestinal Graft-Versus-Host-Disease (GVHD) After Donor Stem Cell Transplant

Who this might be right for
Accelerated Phase Chronic Myelogenous LeukemiaAdult Acute Lymphoblastic Leukemia in RemissionAdult Acute Myeloid Leukemia in Remission+111 more
Fred Hutchinson Cancer Center 20
Post-approval studies (Phase 4)Study completedNCT03713645
What this trial is testing

Dosing Strategies for de Novo Once-daily Extended Release Tacrolimus (LCPT) in Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Temple University 36
Post-approval studies (Phase 4)Study completedNCT00238953
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in de Novo Kidney Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis 30
Post-approval studies (Phase 4)Study completedNCT00537862
What this trial is testing

Efficacy and Safety of Enteric-coated Mycophenolate Sodium (EC-MPS) in a Cyclosporine Microemulsion Based Regimen in de Novo Living Donor Kidney Transplant Recipients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals 200
Testing effectiveness (Phase 2)Study completedNCT02921789
What this trial is testing

Study to Assess the Efficacy and Safety of Bleselumab in Preventing the Recurrence of Focal Segmental Glomerulosclerosis in de Novo Kidney Transplant Recipients

Who this might be right for
Kidney TransplantationPrimary Focal Segmental Glomerulosclerosis (FSGS)
Astellas Pharma Global Development, Inc. 67
Large-scale testing (Phase 3)Study completedNCT03507829
What this trial is testing

Insulin Therapy for the Prevention of New Onset Diabetes After Transplantation Prospective Study in Non-Diabetic De Novo Kidney Transplant Recipients

Who this might be right for
Hyperglycemia
Medical University of Vienna 263
Large-scale testing (Phase 3)Study completedNCT00239811
What this trial is testing

Long Term Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Post-approval studies (Phase 4)UnknownNCT00693446
What this trial is testing

Compare Sirolimus Versus Tacrolimus In De Novo Simultaneous Pancreas- Kidney Allograft Recipients Receiving An Induction Therapy With Antithymocyte Globulin Plus Mycophenolate Mofetil Plus Corticosteroids

Who this might be right for
Pancreas TransplantationKidney Transplantation
Nantes University Hospital 118
Large-scale testing (Phase 3)Study completedNCT00239785
What this trial is testing

Efficacy and Safety of FTY720 in de Novo Adult Renal Transplant Recipients

Who this might be right for
Renal Transplantation
Novartis Pharmaceuticals 684
Post-approval studies (Phase 4)Study completedNCT02267512
What this trial is testing

Efficacy and Safety of Two Anti-T-lymphocyte Immune Globulin (ATG-F) Induction Regimens in Anew Kidney Transplant Patients

Who this might be right for
De Novo Kidney Transplant Patients
Astellas Pharma Inc 280
Large-scale testing (Phase 3)Study completedNCT00014391
What this trial is testing

Ribavirin With or Without Monoclonal Antibody Therapy in Treating Patients Who Develop RSV Pneumonia Following Peripheral Stem Cell Transplantation

Who this might be right for
Cancer
Fred Hutchinson Cancer Center
Large-scale testing (Phase 3)WithdrawnNCT00729768
What this trial is testing

Evaluate Efalizumab Compared With Cyclosporine As an Immunosuppressant Regimen in De Novo Renal Transplantation

Who this might be right for
Kidney Transplantation
Genentech, Inc.
Large-scale testing (Phase 3)Study completedNCT00098241
What this trial is testing

Safety & Efficacy of Certican in Pediatric de Novo Renal Transplant Patients

Who this might be right for
Kidney Transplantation
Novartis Pharmaceuticals 45
Large-scale testing (Phase 3)Ended earlyNCT01442337
What this trial is testing

Evaluate the Effect of ASP8597 in Adult Kidney Transplant Patients

Who this might be right for
Kidney Transplantation
Astellas Pharma Inc 21
Testing effectiveness (Phase 2)Study completedNCT00765661
What this trial is testing

Pharmacokinetics of LCP-Tacro(TM) Once Daily And Prograf® Twice A Day in Adult De Novo Kidney Transplant Patients

Who this might be right for
Kidney FailureRenal Failure
Veloxis Pharmaceuticals 63
Testing effectiveness (Phase 2)Ended earlyNCT00617929
What this trial is testing

Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant

Who this might be right for
Cancer
Masonic Cancer Center, University of Minnesota 12
Not applicableWithdrawnNCT01284257
What this trial is testing

Observational Registry Study of Renal Transplant Patients

Who this might be right for
Kidney Transplant
Novartis Pharmaceuticals
Testing effectiveness (Phase 2)Enrolling By InvitationNCT06751602
What this trial is testing

Belumosudil for Abrogation of Interstitial Fibrosis and Tubular Atrophy Following Kidney Transplantation

Who this might be right for
Rejection Chronic Renal
The Methodist Hospital Research Institute 40
Post-approval studies (Phase 4)Looking for participantsNCT05242315
What this trial is testing

Extended-Release Tacrolimus Following Liver Transplantation

Who this might be right for
Liver Transplant; ComplicationsRenal InsufficiencyImmunosuppressant Adverse Reaction+2 more
University of Alberta 94
Post-approval studies (Phase 4)UnknownNCT03828682
What this trial is testing

Veloxis de Novo Kidney Transplant ECSWD

Who this might be right for
Kidney TransplantationImmunosuppression
Simon Tremblay, PharmD, PhD 60
Next Page